Navigation Links
UCF professor develops vaccine to protect against black plague bioterror attack
Date:7/30/2008

A University of Central Florida researcher may have found a defense against the Black Plague, a disease that wiped out a third of Europe's population in the Middle Ages and which government agencies perceive as a terrorist threat today.

UCF Professor Henry Daniell and his team have developed a vaccine that early research shows is highly effective against the plague. Findings of his National Institutes of Health and USDA funded research appear in the August edition of Infection and Immunity. The vaccine, which is taken orally or by injection, was given to rats at UCF and the efficacy was evaluated by measuring immunity (antibody) developed in their blood.

All untreated rats died within three days while all orally immunized animals survived this challenge with no traces of the plague in their bodies. The rats were exposed to a heavy dose of Yersinia Pestis bacteria, which causes the plague, at the U.S. Army Medical Research Institute of Infectious Diseases in Maryland. It is one of a few labs in the world authorized to store and work with the highly dangerous agent.

"We are very excited because it appears the oral vaccine is even more effective than traditional injectable vaccine," Daniell said. "This could really make a difference."

In the event of a bioterror attack, the oral form makes the vaccine practical, as the distribution of pills would be much quicker and likely more effective because no special skills or sterile needles are needed to administer them.

"It worked beautifully," Daniell said. "It's expensive to create an injectible vaccine. But with oral vaccines, it is quite cheap. You grow your plants and then you convert them into capsules."

The plague had a deadly impact on early Europe, it continues to make appearances today in places like Africa and Asia. The World Health Organization reports at least 2,000 cases of the plague annually. The most recent outbreak in 2005 killed 56 people
'/>"/>

Contact: Zenaida Gonzalez Kotala
zkotala@mail.ucf.edu
407-446-6567
University of Central Florida
Source:Eurekalert

1

GOOD

Page: 1 2 3

Related biology news :

1. UT Knoxville professor finds unexpected key to flowering plants diversity
2. National Institutes of Health award Williams professor $217,710 research grant
3. NJIT architect professor advocates best-building practices for high wind regions
4. Professor Brian Greenwood awarded first Hideyo Noguchi Africa Award
5. McMaster University engineering professor receives Humboldt Research Award
6. USF professor gives historical look at physiology and WWII air war
7. NYU dental professor discovers biological clock linking tooth growth to other metabolic processes
8. MIT professor to discuss future of biofuels
9. ASU professor helps solve mystery of glassy water
10. Professors video series explains all facets of Earth
11. JDRF awards University of Copenhagen professor with grant to conduct innovative diabetes research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ngle bacterial gene into yeast, researchers from D...chieved three improvements in bioethanol productio... less acetate and elimination of the major by-prod...d in the scientific journal Applied and Environme...is made by the yeast Saccharomyces cerevisiae from...
(Date:11/20/2009)... German . , In the current online issue of ...nie Eyerich and Dr. Kilian Eyerich together with t...stituto Dermopatico dell,Immacolata in Rome, prese... milestone on the way to developing new treatment ...riasis and allergic reactions and potentially also...
(Date:11/20/2009)... disease (COPD), a respiratory disease commonly kn...rth leading cause of death worldwide. 600 million...yet to find any real treatment or cure, Grace Parr...y of Western Ontario in London, Canada, is using v... the disease. , Parraga is a scientist in th...
Breaking Biology News(10 mins):Delft breakthrough in bioethanol production from agricultural waste 2Discovery of new type of immune cells regulating inflammation in chronic diseases 2Gaining a better picture of lung disease 2Perrigo Receives FDA Approval to Market Cherry and Cinnamon Flavored Nicotine Lozenges 51471 1Perrigo Receives FDA Approval to Market Cherry and Cinnamon Flavored Nicotine Lozenges 51471 2Study Evaluating Efficacy and Safety of Two Low dose Regimens of PREMARIN Vaginal Cream for the Treatment of Moderate to Severe Vaginal Atrophy Now Pu 51467 1Study Evaluating Efficacy and Safety of Two Low dose Regimens of PREMARIN Vaginal Cream for the Treatment of Moderate to Severe Vaginal Atrophy Now Pu 51467 2Study Evaluating Efficacy and Safety of Two Low dose Regimens of PREMARIN Vaginal Cream for the Treatment of Moderate to Severe Vaginal Atrophy Now Pu 51467 3Study Evaluating Efficacy and Safety of Two Low dose Regimens of PREMARIN Vaginal Cream for the Treatment of Moderate to Severe Vaginal Atrophy Now Pu 51467 4Study Evaluating Efficacy and Safety of Two Low dose Regimens of PREMARIN Vaginal Cream for the Treatment of Moderate to Severe Vaginal Atrophy Now Pu 51467 5Study Evaluating Efficacy and Safety of Two Low dose Regimens of PREMARIN Vaginal Cream for the Treatment of Moderate to Severe Vaginal Atrophy Now Pu 51467 6First Catalog Cancer Biochip for Sequence Capture Now Available from febit 12991 1First Catalog Cancer Biochip for Sequence Capture Now Available from febit 12991 2
...ms and rivers, affecting the number and variety of...niversity study has found. , Rivers and streams a...m important links with surrounding habitats, yet l...ical effects of climate change on these running-wa...Brianne in central Wales, led by Professor Steve O...
...nt the immune system from launching an all-out fig...ity of a nutrient "floodgate" that serves to prote...heir findings appear in the May 4, 2007 issue of t...e researchers found that animals lacking a protein...te inflammation in deep pockets of visceral fat. T...
...are ridding diabetic patients of the superbug MRSA...rofessor Andrew Boulton and his team used green bo...e foot ulcers were contaminated with MRSA and foun...hree weeks, much quicker than the 28-week duration...ulton, who published the results in the journal Di...
Other Biology News:Keeping the immune system from starting a 'food fight' 2Maggots rid patients of MRSA 2
(Date:11/20/2009)...n American countries have an opportunity to take t...chers from the University of Valencia (UV), workin...ed the productive fabric of the Spanish biotechnol...d and plant sectors have more clout than those in ...pplied to food and plants has been overlooked by t...
(Date:11/20/2009)...EATTLE, Nov. 20 Cell The...nced today that the Ninth Circuit Court of Appeals...at CTI should be allowed to pursue all of its clai...o the District Court for trial. CTI filed a compl...rty reimbursement consultant for CTI,s product TRI...
(Date:11/19/2009)...LE, Nov. 19 Omeros Corpo...financial results for the third quarter ended Sept...er 30, 2009, Omeros reported a net loss of $3.9 mi...ss of $7.4 million, or $2.54 per share, for the sa...mber 30, 2009, the Company reported a net loss of ...
(Date:11/19/2009)...ALVERN, Pa. and WALTHAM, Mass., Nov. 19 /PRNewswir...on Resources find that the leading driver of antib...is broad-spectrum activity against gram-positive a...organisms that can cause nosocomial pneumonia, sur...imarily for agents that provide appropriate covera...
Breaking Biology Technology:Spanish biotechnology should focus on food and plant sectors to be more competitive 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3
...irstlogic have announced an OEM agreement to embed...ess Objects , new data integration platform. Data ...cleansing. , ,"Data credibility has become extreme...terprise performance," said Sachin Chawla, vice pr... ,She said the combined product is intended to ens...
...ressions. And I have to admit that when my former...n the January 2002 issue of DEMOletter, I was rath...tomized confetti sold over the Internet. Dot-com ...s certain that this cute little party supply site...een more wrong. More than two years later, Confot...
...sed attacks are surging and may pose the next sign...(IT) operations. That is one of the key findings o...workforce from CompTIA , the Computing Technology...0 organizations found that 36.8 percent were plagu...t six months. Thats up from 25 percent in last yea...
Other Biology Technology:Confoti: Revisiting a dotcom business model 2Confoti: Revisiting a dotcom business model 3Confoti: Revisiting a dotcom business model 4Confoti: Revisiting a dotcom business model 5Browser-based attacks may pose next big IT security nightmare 2
Mouse Anti-Cohesin (Scc1 / Rad21) Monoclonal Antibody, Unconjugated, Clone CM110-2C10 from MBL International
Chicken Anti-Human Proline-serine-threonine phosphatase-interacting protein 2 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Mouse Anti-Human gamma Glutamyl Transferase (gammaGT) Monoclonal Antibody, Unconjugated from AnaSpec
...to Cholesterol Oxidase Immunogen Cholesterol Oxi...ross-reacts with bacteria. Not yet tested in other...dases exist as both type I and type II oxidases an...ition, they are important as clinical reagents, po...
Biology Products: